Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/21/17 → 3/21/20 |
Funding
- PRA Health Sciences (Prot# GS-US-342-4022)
- Gilead Sciences, Inc. (Prot# GS-US-342-4022)
Prot# GS-US-342-4022: A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Subjects with Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis
- Flamm, Steven L (PD/PI)
Project: Research project